Literature DB >> 25598214

A novel role for central ACBP/DBI as a regulator of long-chain fatty acid metabolism in astrocytes.

Khalil Bouyakdan1, Bouchra Taïb, Lionel Budry, Shangang Zhao, Demetra Rodaros, Ditte Neess, Susanne Mandrup, Nils J Faergeman, Thierry Alquier.   

Abstract

Acyl-CoA-binding protein (ACBP) is a ubiquitously expressed protein that binds intracellular acyl-CoA esters. Several studies have suggested that ACBP acts as an acyl-CoA pool former and regulates long-chain fatty acids (LCFA) metabolism in peripheral tissues. In the brain, ACBP is known as Diazepam-Binding Inhibitor, a secreted peptide acting as an allosteric modulator of the GABAA receptor. However, its role in central LCFA metabolism remains unknown. In the present study, we investigated ACBP cellular expression, ACBP regulation of LCFA intracellular metabolism, FA profile, and FA metabolism-related gene expression using ACBP-deficient and control mice. ACBP was mainly found in astrocytes with high expression levels in the mediobasal hypothalamus. We demonstrate that ACBP deficiency alters the central LCFA-CoA profile and impairs unsaturated (oleate, linolenate) but not saturated (palmitate, stearate) LCFA metabolic fluxes in hypothalamic slices and astrocyte cultures. In addition, lack of ACBP differently affects the expression of genes involved in FA metabolism in cortical versus hypothalamic astrocytes. Finally, ACBP deficiency increases FA content and impairs their release in response to palmitate in hypothalamic astrocytes. Collectively, these findings reveal for the first time that central ACBP acts as a regulator of LCFA intracellular metabolism in astrocytes. Acyl-CoA-binding protein (ACBP) or diazepam-binding inhibitor is a secreted peptide acting centrally as a GABAA allosteric modulator. Using brain slices, cortical, and hypothalamic astrocyte cultures from ACBP KO mice, we demonstrate that ACBP mainly localizes in astrocytes and regulates unsaturated but not saturated long-chain fatty acids (LCFA) metabolism. In addition, ACBP deficiency alters FA metabolism-related genes and results in intracellular FA accumulation while affecting their release. Our results support a novel role for ACBP in brain lipid metabolism. FA, fatty acids; KO, knockout; PL, phospholipids; TAG, triacylglycerol.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  acyl-CoA; astrocytes; endozepines; fatty acid esterification; fatty acid oxidation; hypothalamus

Mesh:

Substances:

Year:  2015        PMID: 25598214     DOI: 10.1111/jnc.13035

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

1.  The gliotransmitter ACBP controls feeding and energy homeostasis via the melanocortin system.

Authors:  Khalil Bouyakdan; Hugo Martin; Fabienne Liénard; Lionel Budry; Bouchra Taib; Demetra Rodaros; Chloé Chrétien; Éric Biron; Zoé Husson; Daniela Cota; Luc Pénicaud; Stephanie Fulton; Xavier Fioramonti; Thierry Alquier
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

2.  Oleic Acid in the Ventral Tegmental Area Inhibits Feeding, Food Reward, and Dopamine Tone.

Authors:  Cecile Hryhorczuk; Zhenyu Sheng; Léa Décarie-Spain; Nicolas Giguère; Charles Ducrot; Louis-Éric Trudeau; Vanessa H Routh; Thierry Alquier; Stephanie Fulton
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

3.  Differential impacts on multiple forms of spatial and contextual memory in diazepam binding inhibitor knockout mice.

Authors:  Ammar L Ujjainwala; Connor D Courtney; Natalia M Wojnowski; Justin S Rhodes; Catherine A Christian
Journal:  J Neurosci Res       Date:  2019-01-25       Impact factor: 4.164

4.  Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.

Authors:  Seyma Bahdoudi; Ikram Ghouili; Mansour Hmiden; Jean-Luc do Rego; Benjamin Lefranc; Jérôme Leprince; Julien Chuquet; Jean-Claude do Rego; Ann-Britt Marcher; Susanne Mandrup; Hubert Vaudry; Marie-Christine Tonon; Mohamed Amri; Olfa Masmoudi-Kouki; David Vaudry
Journal:  Cell Mol Life Sci       Date:  2017-12-20       Impact factor: 9.261

5.  3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.

Authors:  David M G Anderson; Raf Van de Plas; Kristie L Rose; Salisha Hill; Kevin L Schey; Anne C Solga; David H Gutmann; Richard M Caprioli
Journal:  J Proteomics       Date:  2016-02-13       Impact factor: 4.044

6.  Differential Brain and Cerebrospinal Fluid Proteomic Responses to Acute Prenatal Endotoxin Exposure.

Authors:  Tik Muk; Allan Stensballe; Oksana Dmytriyeva; Anders Brunse; Ping-Ping Jiang; Thomas Thymann; Per Torp Sangild; Stanislava Pankratova
Journal:  Mol Neurobiol       Date:  2022-01-21       Impact factor: 5.590

Review 7.  From benzodiazepines to fatty acids and beyond: revisiting the role of ACBP/DBI.

Authors:  Thierry Alquier; Catherine A Christian-Hinman; Julieta Alfonso; Nils J Færgeman
Journal:  Trends Endocrinol Metab       Date:  2021-09-23       Impact factor: 12.015

Review 8.  Role of non-neuronal cells in body weight and appetite control.

Authors:  Pilar Argente-Arizón; Alejandra Freire-Regatillo; Jesús Argente; Julie A Chowen
Journal:  Front Endocrinol (Lausanne)       Date:  2015-03-26       Impact factor: 5.555

9.  Glial Endozepines Inhibit Feeding-Related Autonomic Functions by Acting at the Brainstem Level.

Authors:  Florent Guillebaud; Clémence Girardet; Anne Abysique; Stéphanie Gaigé; Rym Barbouche; Jérémy Verneuil; André Jean; Jérôme Leprince; Marie-Christine Tonon; Michel Dallaporta; Bruno Lebrun; Jean-Denis Troadec
Journal:  Front Neurosci       Date:  2017-05-30       Impact factor: 4.677

Review 10.  Microglial Lipid Biology in the Hypothalamic Regulation of Metabolic Homeostasis.

Authors:  Andrew Folick; Suneil K Koliwad; Martin Valdearcos
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-27       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.